Summit Therapeutics Inc. (NASDAQ:SMMT) is held by 202 institutional investors per 13F filings through December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 31 Mar, 2026 | 36,391,063 | 0 | 0.00% | $689,974,554.00 |
| BAKER BROS. ADVISORS LP | 31 Mar, 2026 | 36,391,063 | 2,668,089 | 7.91% | $636,479,692.00 |
| FMR LLC | 31 Mar, 2026 | 13,360,807 | 4,442,920 | 49.82% | $233,680,513.00 |
| VANGUARD GROUP INC | 31 Mar, 2026 | 11,177,220 | -202,508 | -1.78% | $195,489,577.00 |
| FMR LLC | 31 Mar, 2026 | 10,853,199 | -2,507,608 | -18.77% | $205,776,661.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 9,653,758 | 291,837 | 3.12% | $183,035,250.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 9,361,921 | 1,998,128 | 27.13% | $163,739,998.00 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 31 Mar, 2026 | 8,277,859 | 8,277,859 | 0.00% | $156,949.00 |
| State Street Corp | 31 Mar, 2026 | 7,028,160 | 391,799 | 5.90% | $133,253,914.00 |
| State Street Corp | 31 Mar, 2026 | 6,636,361 | 274,425 | 4.31% | $116,069,954.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 5,711,802 | 5,711,802 | 0.00% | $108,295,766.00 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 31 Mar, 2026 | 5,233,252 | 5,233,252 | 0.00% | $99,222,458.00 |
| UBS Group AG | 31 Mar, 2026 | 3,680,315 | 2,809,596 | 322.68% | $69,778,773.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 3,315,854 | 168,374 | 5.35% | $62,886,714.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 3,147,480 | 14,745 | 0.47% | $55,063,414.00 |
| CITADEL ADVISORS LLC | 31 Mar, 2026 | 2,475,708 | 2,272,996 | 1,121.29% | $43,300,133.00 |
| D. E. Shaw & Co., Inc. | 31 Mar, 2026 | 2,242,229 | 1,826,945 | 439.93% | $42,512,661.00 |
| Morgan Stanley | 31 Mar, 2026 | 1,650,591 | 724,012 | 78.14% | $31,295,209.00 |
| Polymer Capital Management (HK) LTD | 31 Mar, 2026 | 1,421,155 | 603,879 | 73.89% | $24,856,001.00 |
| Pictet Asset Management Holding SA | 31 Mar, 2026 | 1,383,775 | -220,388 | -13.74% | $24,381,751.00 |